181696-37-7

Basic information

• Product Name: 4-(5-(methoxymethyl)-3-phenylisoxazol-4-yl)benzenesulfonamide
• Synonyms: 4-(5-(methoxymethyl)-3-phenylisoxazol-4-yl)benzenesulfonamide
• CAS NO: 181696-37-7
• Molecular Weight: 344.391
• Mol File: 181696-37-7.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 4-(5-(methoxymethyl)-3-phenylisoxazol-4-yl)benzenesulfonamide(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(5-(methoxymethyl)-3-phenylisoxazol-4-yl)benzenesulfonamide(181696-37-7)
• EPA Substance Registry System: 4-(5-(methoxymethyl)-3-phenylisoxazol-4-yl)benzenesulfonamide(181696-37-7)

Safety Data

• Hazardous Substances Data: 181696-37-7(Hazardous Substances Data)

Upstream product

• 181695-81-8 4-(5-hydroxymethyl-3-phenylisoxazol-4-yl)benzenesulfonamide 

Relevant articles and documents

Radiosynthesis and in vivo evaluation of [11C]MOV as a PET imaging agent for COX-2

Radiosynthesis and in vivo evaluation of [11C]4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (methoxy analogue of valdecoxib, [11C]MOV), a COX-2 inhibitor, was conducted in rat and baboon. Synthesis of t

Isoxazole compounds as cyclooxygenase inhibitors

A class of substituted isoxazolyl compounds is described for use in treating cyclooxygenase-2 related disorders. Compounds of particular interest are defined by Formula I STR1 wherein R1, R2, and R3, are described in the specification.